Revealing the Landscape of Synaptic Diversity by Cell type- and Synapse-specific Proteomics and Transcriptomics
This project aims to elucidate the molecular diversity of synapses by analyzing their proteomes and transcriptomes across different brain areas, using advanced sorting and profiling techniques.
Projectdetails
Introduction
Synapses differ in their shape, size, and function and exhibit ongoing plasticity during the development and modification of neural circuits. The structural diversity of synapses is largely known, whereas the molecular diversity of synapses is much less well understood. While most synaptic molecules have been identified by immunolabeling and bulk proteomic approaches, the complement of proteins present at individual synapse types, as well as their stoichiometric relationships with other molecules, remains unknown.
Current Classification
Indeed, our current classification mostly relies on neurotransmitter/receptor phenotypes, leading to broad descriptors like “excitatory” or “inhibitory” synapses. Because the function of the synapse, as well as its ability to change, is largely determined by the quality and quantity of molecules that inhabit it, it is essential to understand synaptic molecular diversity.
Aims of the Proposal
The aims of this proposal are to:
- Determine the proteomes and transcriptomes of genetically identifiable synaptic populations in different brain areas.
- Determine the molecular diversity in these same synapse populations using transcriptomic analysis of individual synapses.
- Assess how these synaptic proteomes, transcriptomes, and the transcriptomic diversity respond to plasticity.
Methodology
To study synaptic proteomes and transcriptomes, we will use Fluorescence-Activated Synaptosome Sorting to purify different synaptic populations (excitatory, inhibitory, dopaminergic) from different brain areas.
We will:
- Use state-of-the-art methods optimized for quantitative transcriptomic and proteomic profiling of very small amounts of sorted synapses.
- Develop a method, SynDrops, for the transcriptomic analysis of individual synapses.
- Examine how synaptic proteomes and transcriptomes change during plasticity.
Expected Outcomes
These studies will reveal the landscape of synaptic diversity within synapse types and across brain areas, allowing the field to probe “diseased” synapses in the future.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.498.575 |
Totale projectbegroting | € 2.498.575 |
Tijdlijn
Startdatum | 1-8-2022 |
Einddatum | 31-7-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EVpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Lysosomal exocytosis of metastable proteins to control synaptic functionThe LEXSYN project aims to investigate lysosomal exocytosis in dendrites to understand its role in synaptic plasticity and neurodegeneration, utilizing advanced imaging and new monitoring tools. | ERC Starting... | € 2.037.356 | 2025 | Details |
Cracking the Synaptic Memory CodeThis project aims to uncover how local protein production at synapses contributes to memory encoding in the brain using advanced imaging and sequencing techniques. | ERC Starting... | € 1.500.000 | 2023 | Details |
Plasticity of neurotransmitter release sites in temporal coding, homeostasis, learning and diseaseThis project aims to explore the mechanisms of synaptic release site plasticity in Drosophila to understand its role in neural function, behavior, and disease treatment. | ERC Consolid... | € 2.000.000 | 2024 | Details |
Combinatorial neuromodulation of internal statesThis project aims to investigate how combinations of neuromodulators influence neuronal dynamics and circuit configurations in the hippocampus-prefrontal circuit during various behavioral states in mice. | ERC Starting... | € 1.499.563 | 2025 | Details |
Axon Initial Segment plasticity: unravelling the mechanisms that control neuronal excitabilityThis project aims to investigate the molecular mechanisms of axon initial segment plasticity in neurons and its implications for network homeostasis and diseases like Angelman Syndrome. | ERC Starting... | € 1.494.740 | 2024 | Details |
Lysosomal exocytosis of metastable proteins to control synaptic function
The LEXSYN project aims to investigate lysosomal exocytosis in dendrites to understand its role in synaptic plasticity and neurodegeneration, utilizing advanced imaging and new monitoring tools.
Cracking the Synaptic Memory Code
This project aims to uncover how local protein production at synapses contributes to memory encoding in the brain using advanced imaging and sequencing techniques.
Plasticity of neurotransmitter release sites in temporal coding, homeostasis, learning and disease
This project aims to explore the mechanisms of synaptic release site plasticity in Drosophila to understand its role in neural function, behavior, and disease treatment.
Combinatorial neuromodulation of internal states
This project aims to investigate how combinations of neuromodulators influence neuronal dynamics and circuit configurations in the hippocampus-prefrontal circuit during various behavioral states in mice.
Axon Initial Segment plasticity: unravelling the mechanisms that control neuronal excitability
This project aims to investigate the molecular mechanisms of axon initial segment plasticity in neurons and its implications for network homeostasis and diseases like Angelman Syndrome.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A synaptic mechanogenetic technology to repair brain connectivityDeveloping a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy. | EIC Pathfinder | € 3.543.967 | 2023 | Details |
A synaptic mechanogenetic technology to repair brain connectivity
Developing a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy.